• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCCT.core 软件评估乳房美容效果的可靠性 - 系统评价。

Reliability of the BCCT.core software in evaluation of breast cosmesis - A systematic review.

机构信息

St George Cancer Care Centre, St George Hospital, Kogarah, New South Wales, Australia.

Centre for Research in Nursing and Health, St George Hospital, Kogarah, New South Wales, Australia.

出版信息

J Med Imaging Radiat Oncol. 2021 Oct;65(6):817-825. doi: 10.1111/1754-9485.13190. Epub 2021 May 10.

DOI:10.1111/1754-9485.13190
PMID:33973358
Abstract

Breast cancer conservative treatment software (BCCT.core) has the potential to provide objective results using digital photographs, thus increasing the reliability, limiting the subjective interpretation and standardising the evaluation of breast cosmesis in patients. The aim of this systematic review was to summarise the empirical evidence regarding the agreement between the BCCT.core and other methods used by health professionals and patients to assess breast cosmesis. The Ovid MEDLINE, Embase, CINAHL, PsycINFO and Scopus databases were systematically searched for studies comparing the agreement between BCCT.core and other methods used to assess breast cosmesis. A total of 14 studies involving 2703 patients were included in the review. In studies where patients undertook self-assessment, the percentage agreement ranged from 69.2% to 74.8% and the kappa values ranged from slight (k = 0.12) to fair agreement. There was a low correlation between the BCCT.core and the Harvard scale when patients assessed cosmetic outcomes using photographs of their breasts (r = 0.165). A 75% and 42.8% agreement was reported in studies where clinicians assessed breast cosmesis by directly visualising the patients' breasts and photographs, respectively. Assessment of breast cosmesis by the expert panel using patient photographs reported a percentage agreement ranging from 25% to 83%. The results of this systematic review demonstrated an overall agreement of fair to moderate between the BCCT.core and the subjective scales used to assess breast cosmesis. However, clinician experience and patient values should be considered in clinical decision-making.

摘要

乳腺癌保乳治疗软件(BCCT.core)具有使用数字照片提供客观结果的潜力,从而提高了可靠性,限制了主观解释,并使患者乳房美容评估标准化。本系统评价的目的是总结有关 BCCT.core 与健康专业人员和患者用于评估乳房美容的其他方法之间一致性的经验证据。系统地检索了 Ovid MEDLINE、Embase、CINAHL、PsycINFO 和 Scopus 数据库,以查找比较 BCCT.core 与用于评估乳房美容的其他方法之间一致性的研究。共有 14 项涉及 2703 名患者的研究纳入了本综述。在患者进行自我评估的研究中,一致性百分比范围为 69.2%至 74.8%,kappa 值范围为轻度(k=0.12)至中度一致。当患者使用乳房照片评估美容结果时,BCCT.core 与哈佛量表之间相关性较低(r=0.165)。当临床医生通过直接观察患者的乳房和照片评估乳房美容时,分别报告了 75%和 42.8%的一致性。使用患者照片由专家小组评估乳房美容,报告的一致性百分比范围为 25%至 83%。本系统评价的结果表明,BCCT.core 与用于评估乳房美容的主观量表之间总体一致性为中度至轻度。然而,在临床决策中应考虑临床医生的经验和患者的价值观。

相似文献

1
Reliability of the BCCT.core software in evaluation of breast cosmesis - A systematic review.BCCT.core 软件评估乳房美容效果的可靠性 - 系统评价。
J Med Imaging Radiat Oncol. 2021 Oct;65(6):817-825. doi: 10.1111/1754-9485.13190. Epub 2021 May 10.
2
Oncoplastic breast-conserving surgery for women with primary breast cancer.原发性乳腺癌患者的肿瘤整形保乳手术。
Cochrane Database Syst Rev. 2021 Oct 29;10(10):CD013658. doi: 10.1002/14651858.CD013658.pub2.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
5
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Injection sclerotherapy for varicose veins.注射硬化疗法治疗静脉曲张。
Cochrane Database Syst Rev. 2021 Dec 10;12(12):CD001732. doi: 10.1002/14651858.CD001732.pub3.
8
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
9
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
10
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.

引用本文的文献

1
Error assessment of subjective estimates of linear breast dimensions versus the objective method.线性乳房尺寸的主观估计与客观方法的误差评估。
Ger Med Sci. 2024 Jul 8;22:Doc07. doi: 10.3205/000333. eCollection 2024.
2
Advancements in Aesthetic Breast Augmentation: Evaluating the Safety, Efficacy, and Naturalistic Outcomes of Ergonomix2 Implants.美学隆胸的进展:评估 Ergonomix2 植入物的安全性、疗效和自然结果。
Aesthetic Plast Surg. 2024 Nov;48(21):4351-4364. doi: 10.1007/s00266-024-03994-3. Epub 2024 Apr 5.
3
Outcomes of reconstructive techniques in breast cancer using BCCT. core software.
使用 BCCT 核心软件进行乳腺癌重建技术的结果。
World J Surg Oncol. 2024 Mar 23;22(1):82. doi: 10.1186/s12957-024-03343-3.
4
Dermoglandular advancement-rotation flap for conservative treatment of breast cancer - description of technique, objective and subjective assessments.皮肤腺体推进旋转皮瓣用于乳腺癌的保守治疗——技术描述、客观和主观评估
Front Oncol. 2023 May 3;13:1137924. doi: 10.3389/fonc.2023.1137924. eCollection 2023.